|
Market Closed -
NYSE
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 2.360 USD | -9.92% |
|
-3.28% | +31.11% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
NYSE
PLX 2.360 $
-9.92%
4.72M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| PLX | 2.360USD | -9.92% | 4.72M $ | |
CBOE
| PLX | 2.355USD | -9.94% | 74.25K $ | |
|
Tradegate
| PBDA | 2.045EUR | -9.91% | 6.14K € | |
|
Börse Stuttgart
| PBDA | 2.025EUR | +0.25% | 0 € | |
|
Deutsche Boerse AG
| PBDA | 2.030EUR | +0.25% | 0 € | |
|
Boerse Muenchen
| PBDA | 2.040EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 2.62 | 3.15 | 3.06 |
| Spread/Res. | -9.92% | -25.08% | -22.88% |
| Spread/Supp. | +3.96% | +24.21% | +53.25% |
| Support | 2.27 | 1.9 | 1.54 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
